Sarah Sharon Gabriel

6PUBLICATIONS
84CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Innate immunityMolecular targetsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 07, 2026
Cost-effectiveness of pembrolizumab as neoadjuvant therapy and in combination with standard of care (SOC) as adjuvant therapy for stage III-IVA resectable locally advanced head and neck squamous cell carcinoma (LA HNSCC) in Switzerland.

|Oct 31, 2025
Stem-like tissue-resident memory T cells control functional heterogeneity and reactivation of T cell memory in the intestine.

Kevin Man, Vinicius A Duarte da Silva, Nikita Potemkin

|Jul 29, 2025
Lymph-node-derived stem-like but not tumor-tissue-resident CD8+ T cells fuel anticancer immunity.

Sharanya K M Wijesinghe, Lisa Rausch, Sarah S Gabriel

|Jan 31, 2025
Stem-like memory and precursors of exhausted T cells share a common progenitor defined by ID3 expression.

Catarina Gago da Graça, Amania A Sheikh, Dane M Newman

|May 15, 2023
CD4+ T cell calibration of antigen-presenting cells optimizes antiviral CD8+ T cell immunity.

Elise Gressier, Jonas Schulte-Schrepping, Lev Petrov

|Apr 07, 2021
Intact TP-53 function is essential for sustaining durable responses to BH3-mimetic drugs in leukemias.

Rachel Thijssen, Sarah T Diepstraten, Donia Moujalled

Pageof 1

Frequent Collaborators

5 joint publications

Axel Kallies

2 joint publications

Chun-Hsi Su

2 joint publications

Kevin Man

2 joint publications

Jan Schröder